Onkure Therapeutics - Class A (OKUR) closed at $2.63 on November 13, 2026, down 12.6% from the previous close, on volume of 891,321 shares (30-day average 377,312).
Data as of November 13, 2026.
13-Nov-2026
No headlines found.
OnKure Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Highlights
Globe Newswire (Wed, 4-Nov 4:05 PM ET)
OnKure Therapeutics to Participate in the Morgan Stanley Global Healthcare Conference
Globe Newswire (Mon, 31-Aug 8:00 AM ET)
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a structure-based drug design platform to develop a pipeline of drug candidates aimed at optimizing efficacy and tolerability. The company has multiple programs focused on targeting oncogenic PI3Ka. Its flagship program is OKI-219. The company operates in one operating segment: clinical research.
Onkure Therapeutics - Class A trades on the NASDAQ stock market under the symbol OKUR.
As of November 13, 2026, OKUR stock price declined to $2.63 with 891,321 million shares trading.
OKUR has a beta of 0.72, meaning it tends to be less sensitive to market movements. OKUR has a correlation of 0.02 to the broad based SPY ETF.
OKUR has a market cap of $108.33 million. This is considered a Micro Cap stock.
Last quarter Onkure Therapeutics - Class A reported $0 in Revenue and -$.36 earnings per share. This fell short of revenue expectation by $-200,000 and exceeded earnings estimates by $.03.
The top ETF exchange traded funds that OKUR belongs to (by Net Assets): VTI, IWM, VXF, IWN, VTWO.
OKUR has underperformed the market in the last year with a return of -16.2%, while the SPY ETF gained +13.4%. In the last 3 month period, OKUR fell short of the market, returning -32.6%, while SPY returned -2.8%. However, in the most recent 2 weeks OKUR has outperformed the stock market by returning +0.4%, while SPY returned -0.2%.
OKUR support price is $2.79 and resistance is $3.23 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that OKUR shares will trade within this expected range on the day.
